Input speech to panel on ethics from Bram Stieltjes, University Hospital Basel at the DayOne Conference 2019 Shaping the future of Health September 9th 2019
Expert Event Legal challenges and opportunities for digital health innovationDayOne
Introduction by Thomas Brenzikofer, DayOne, Basel Area Business & Innovation
Greenfield or jungle? Navigating the legal landscape for digital healthcare innovation
At first sight, it’s hard not to agree that dealing with the legal aspects of creating healthcare innovation is — although necessary — a rather unsexy topic. So it comes as no surprise that the DayOne Experts Event “Legal challenges and opportunities for healthcare innovation”, held online on September 30, attracted a slightly smaller audience than when the talks usually concern revolutionary new pieces of digital technology ready to disrupt healthcare as we know it — for the better.
Future of aging day one 20200630 zaynakhayatDayOne
This document discusses the future of aging and outlines several shifts that are expected to occur. It summarizes a book on the topic that explores how aging is transforming in areas like identity, community, health interventions, and technology. The document presents examples of emerging trends like reframing what it means to age, new models for aging communities, a shift from treating illness to empowering health, and technologies that can enhance independence and quality of life for older adults.
Value-based Healthcare - Towards a systems approach in chronic diseasesnDayOne
Role of patient journey in science, predictive modeling and high-risk patients in early stages of disease progression, in real world context. Presented by Michael Rebhan, Novartis at the DayOne Basel event in June 2020
Value-based Healthcare today and tomorrow by Deloitte.DayOne
VBHC today and tomorrow
There is an increasing need for a value-based healthcare model based on holistic patient and health system outcomes, which can only be achieved through genuine collaboration between stakeholders. Value-based contracts require defining appropriate outcome measures, collecting and analyzing real-world data, and addressing challenges such as misaligned incentives among payers, providers, and pharmaceutical companies. The COVID-19 pandemic is likely to accelerate trends in healthcare such as greater emphasis on value-based care, data analytics, technology innovation, and patient engagement. Post-COVID, there are opportunities for life sciences companies to strengthen evidence of value, support health system capacity and digital adoption, and engage differently with regulators and payers.
This document discusses value-based healthcare and consists of presentations from a DayOne Experts event on June 18, 2020. It explores why value-based healthcare is needed, how it is implemented, and who benefits from it. The event included breakout sessions on how COVID-19 could catalyze value-based approaches, how it may change disease treatment and research, its potential to trigger innovation and new business models, and how to define and measure healthcare value from the patient perspective.
The Aging Well Catalyst Project would involve a series of 5 workshops bringing together stakeholders from areas like healthcare, technology, and senior care to identify innovation opportunities for an aging society. The outputs would be published in a series of white papers and culminate in a public event. The Aging Well Accelerator would select and accelerate the top 3 startups in technologies supporting healthy aging over 6 months to help their path to market. Both projects aim to drive innovation and collaboration around aging well.
How can digital bridge the mental health gaps?
Mental health is a story of gaps. This was made clear by all the speakers and panelists at DayOne’s most recent Expert Meeting titled “Measuring the Unmeasurable - will digital pave the way for new treatments in mental health?” which took place in Basel. Check out the slides from the event here.
20191203 DOE Data Driven Healthcare- Expert EventDayOne
This document summarizes a presentation on data-driven healthcare given at the DayOne Experts conference in Basel on December 3rd, 2019. The presentation discusses whether the healthcare system is ready for data-driven approaches and what is needed to enable new data-driven health solutions. It notes that while digitalization in Swiss medical practices is increasing, coordination between different parts of the treatment chain remains a challenge. The Swiss Personalized Health Network aims to connect different health data sources and establish national infrastructure to enable interoperable exchange of health data for research purposes. University hospitals are working to structure, standardize and integrate different types of clinical and research data according to SPHN requirements.
Healthcare delivery in the periphery workshop outputDayOne
This document summarizes a tri-national workshop on healthcare delivery in peripheral regions. The workshop brought together participants from Germany, France, and Switzerland to identify challenges in peripheral healthcare, develop collaborative projects to address these challenges, and plan next steps. Three priority projects were selected: 1) A platform for hospitals to share best practices and develop an adherence app, 2) A workshop on technological solutions to attract physicians to peripheral areas, and 3) An exchange program for nurses and nursing students to collaborate with technology companies and work towards harmonizing training across borders. Immediate next steps included reporting outcomes to relevant conferences and planning an expert workshop in early 2020.
What does “patient centricity” really mean and how is it actually done? This was the driving question of the DayOne Experts Meeting in Basel, co-hosted by Arcondis.
YouROK delivers a positive emotional health platform to help kids, families and professionals prevent mental health issues and build healthier families. The platform includes an app that builds emotional resilience while measuring deterioration in emotional well-being to proactively offer targeted treatment. Using deep learning to assess emotional health, YouROK keeps parents and professionals informed of a child's mental health status through a dashboard and alerts.
This document provides information about Shanghai, China including its population, transportation infrastructure, universities, and healthcare system. It discusses several major hospitals in Shanghai - Renji Hospital, Zhongshan Hospital, and Fudan Cancer Institute. It provides details on the capacity, staffing, and services of each hospital. The document raises questions about ethics, data, privacy, and how to optimize hospitals in China given challenges with lack of universal healthcare, doctor shortages, and hospital overcrowding.
How start-up funding in digital health can workDayOne
The document outlines different stages of start-up funding for digital health companies, including idea stage with the founder's own money, co-founder stage with two owners, family and friends investing, seed rounds with business angels, Series A rounds with venture capitalists, and successful IPOs. It notes that most start-ups fail due to running out of money and not engaging with potential investors, experts, regulators, payers, users, and patients who could help. The presentation encourages understanding these stakeholders and what can be done to succeed in obtaining funding.
Input speech to panel on future financing by Julien Salaberry from Galen Growth Asia at introduce the DayOne Conference 2019 Shaping the future of Health September 9th 2019
The DayOne Conference 2019 was held on September 9th at FHNW in Muttenz. The one-day conference focused on shaping the future of health and included panels with patients and industry professionals, sessions on ethics, financing innovation, and a workshop. There were over 450 participants, including 30 projects/entrepreneurs, 40 volunteers, and a keynote from digital health futurist Maneesh Juneja. The conference was organized by the DayOne team and supported various partners to bring together over 1500 healthcare innovators in the Basel area.
The document discusses shaping the future of health care and how AI could be used to improve patient care and staff experience. It describes how AI technologies like neural networks are being developed to analyze CCTV footage to predict medical emergencies and alerts first responders. However, care must be taken to avoid discrimination and harm when using these automated models. The document also questions how AI can be used to create a better world and return on investment for health systems.
Day one conference projects with journey mapsDayOne
DayOne Conference 2019 projects and journey maps. 30 ventures presented their solutions and together with conference participants built a journey map of their future.
Hepatocarcinoma today between guidelines and medical therapy. The role of sur...Gian Luca Grazi
Today more than ever, hepatocellular carcinoma therapy is experiencing profound and substantial changes.
The association atezolizumab (ATEZO) plus bevacizumab (BEVA) has demonstrated its effectiveness in the post-operative treatment of patients, improving the results that can be achieved with liver resections. This after the failure of the use of sorafenib in the already historic STORM study.
On the other hand, the prognostic classification of BCLC is now widely questioned. It is now well recognized that the indications for surgery for patients with hepatocellular carcinoma are certainly narrow in BCLC and no longer reflect what is common everyday clinical practice.
Today, the concept of multiparametric therapeutic hierarchy, which makes the management of patients with hepatocellular carcinoma much more flexible and allows the best therapy for the individual patient to be identified based on their clinical characteristics, is gaining more and more importance.
The presentation traces these profound changes that are taking place in recent years and offers a modern vision of the management of patients with hepatocellular carcinoma.
Descoperă Bucuria Vieții Sănătoase cu Jurnalul Fericirii Life Care - Iulie 2024!
Gata să te bucuri de o vară vibrantă și plină de energie? Life Care îți vine în ajutor cu Jurnalul Fericirii din Iulie 2024, un ghid complet pentru o viață armonioasă și echilibrată.
Pe parcursul a cateva de pagini pline de informații utile și inspirație, vei descoperi:
Sfaturi practice pentru o alimentație sănătoasă:
Rețete delicioase și ușor de preparat: Bucură-te de preparate gustoase și nutritive, perfecte pentru zilele călduroase de vară.
Recomandări pentru o alimentație echilibrată: Asigură-ți aportul necesar de nutrienți esențiali pentru un organism sănătos și plin de vitalitate.
Sfaturi pentru alegeri alimentare inteligente: Învață cum să faci cumpărături sănătoase și să eviți tentațiile nesănătoase.
Trucuri pentru un stil de viață activ:
Rutine de exerciții fizice adaptate nevoilor tale: Găsește antrenamente potrivite pentru a te menține în formă și energic pe tot parcursul verii.
Idei de activități în aer liber: Descoperă modalități distractive de a te bucura de vremea frumoasă și de a petrece timp de calitate cu cei dragi.
Sfaturi pentru un somn odihnitor: Asigură-ți un somn profund și reparator pentru a te trezi revigorat și pregătit pentru o nouă zi.
Sfaturi pentru o stare de bine mentală:
Tehnici de relaxare și gestionare a stresului: Învață cum să te relaxezi și să faci față provocărilor zilnice cu mai multă ușurință.
Sfaturi pentru cultivarea optimismului și a gândirii pozitive: Descoperă cum să abordezi viața cu o perspectivă optimistă și să atragi mai multă bucurie în ea.
Recomandări pentru a te conecta cu natura: Bucură-te de beneficiile naturii asupra stării tale mentale și emoționale.
Bonus:
Oferte exclusive la produsele Life Care: Beneficiază de reduceri și promoții speciale la o gamă largă de produse pentru o viață sănătoasă.
Concursuri și premii: Participă la concursuri distractive și câștigă premii valoroase.
Jurnalul Fericirii Life Care - Iulie 2024 este mai mult decât o simplă revistă. Este un ghid complet și personalizat pentru a te ajuta să obții o viață mai sănătoasă, mai fericită și mai plină de satisfacții.
Nu rata această șansă de a te bucura de vară la maximum! Descoperă Jurnalul Fericirii Life Care - Iulie 2024 astăzi!
Comandă-ți exemplarul acum și fă un pas important către o viață mai bună!
#JurnalulFericirii #LifeCare #Iulie2024 #ViataSanatoasa #Bunastare #Fericire #Oferte #Concursuri #Premii
Ontotext’s Clinical Trials Eligibility Design Assistant helps with one of the most challenging tasks in study design: selecting the proper patient population.
JMML is a rare cancer of blood that affects young children. There is a sustained abnormal and excessive production of myeloid progenitors and monocytes.
Why Does Seminal Vesiculitis Causes Jelly-like Sperm.pptxAmandaChou9
Seminal vesiculitis can cause jelly-like sperm. Fortunately, herbal medicine Diuretic and Anti-inflammatory Pill can eliminate symptoms and cure the disease.
Hemodialysis: Chapter 8, Complications During Hemodialysis, Part 2 - Dr.GawadNephroTube - Dr.Gawad
- Video recording of this lecture in English language: https://youtu.be/FHV_jNJUt3Y
- Video recording of this lecture in Arabic language: https://youtu.be/D5kYfTMFA8E
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Exploring Alternatives- Why Laparoscopy Isn't Always Best for Hydrosalpinx.pptxFFragrant
Not all women with hydrosalpinx should choose laparoscopy. Natural medicine Fuyan Pill can also be a nice option for patients, especially when they have fertility needs.
EXPERIMENTAL STUDY DESIGN- RANDOMIZED CONTROLLED TRIALRishank Shahi
Randomized controlled clinical trial is a prospective experimental study.
It essentially involves comparing the outcomes in two groups of patients treated with a test treatment and a control treatment, both groups are followed over the same period of time. Prepare a plan of study or protocol
a. Define clear objectives
b. State the inclusion and exclusion criteria of case
c. Determine the sample size, place and period of study
d. Design of trial (single blind, double blind and triple blind method)
2. Define study population: Most often the patients are chosen from hospital or from the community. For example, for a study for comparison of home and sanatorium treatment, open cases of tuberculosis may be chosen.
3. Selection of participants by defined criteria as per plan:
Selection of participants should be done with precision and should be precisely stated in writing so that it can be replicated by others. For example, out of open cases of tuberculosis those who fulfill criteria for inclusion may be selected (age groups, severity of disease and treatment taken or not, etc.)
Randomization ensures that participants have an equal chance to be assigned to one of two or more groups:
One group gets the most widely accepted treatment (standard treatment/ gold standard)
The other gets the new treatment being tested, which researchers hope and have reason to believe will be better than the standard treatment
Subject variation: First, there may be bias on the part of the participants, who may subjectively feel better or report improvement if they knew they were receiving a new form of treatment.
Observer bias: The investigator measuring the outcome of a therapeutic trial may be influenced if he knows beforehand the particular procedure or therapy to which the patient has been subjected.
Evaluation bias: There may be bias in evaluation - that is, the investigator(Analyzer) may subconsciously give a favorable report of the outcome of the trial.
Co-intervention:
participants use other therapy or change behavior
Study staff, medical providers, family or friends treat participants differently.
Biased outcome ascertainment:
participants may report symptoms or outcomes differently or physicians
Investigators may elicit symptoms or outcomes differently
A technique used to prevent selection bias by concealing the allocation sequence from those assigning participants to intervention groups, until the moment of assignment.
Allocation concealment prevents researchers from influencing which participants are assigned to a given intervention group.
All clinical trials must be approved by Institutional Ethics Committee before initiation
It is mandatory to register clinical trials with Clinical Trials Registry of India
Informed consent from all study participants is mandatory.
A preclinical trial is a stage of research that begins before clinical trials, and during which important feasibility and drug safety data are collected.
Following points high.
2. Dürrenmatt
• Who is struggling with data availability in Medicine?
• Who has read Durrenmatt's Physicists?
“What is thought, cannot be undone” …and will
inevitably lead to its ultimate thinkable consequence
3. Is Dürrenmatt too sinister?
Atomic energy, Atomic bomb, Atomic warfare
4. Questions
• Should we stop ourselves?
• Can we stop ourselves?
• Regulations vs. moral standard
• Global vs. local actions
5. Considerations
• We will suffer from a status quo bias!1
Bostrom et al., Ethics 2006
• Contributing data vs money (sharing is no option)
• Counteract neo-liberal thinking when it comes to
healthcare
• Use technology to make this shift efficient